DarshanTalks Podcast

406 Episoder

1. Will New Tariffs Disrupt Your Next Pharma Deal?

   Udgivet: 26.2.2025
2. Protecting Patient Data in a Changing Regulatory Landscape

   Udgivet: 25.2.2025
3. Off-Label Promotion Changes in 2025

   Udgivet: 24.2.2025
4. Turning Physicians into Leaders

   Udgivet: 21.2.2025
5. Key Regulatory Agencies in Pharma M&A

   Udgivet: 20.2.2025
6. Does E6 (R3) Blur the Line Between GCP and Privacy Laws?

   Udgivet: 19.2.2025
7. RFK Jr. Confirmed as HHS Secretary: What It Means for Healthcare Policy

   Udgivet: 18.2.2025
8. America’s Research Future in Jeopardy

   Udgivet: 15.2.2025
9. Trump Administration’s NIH cuts: Will they cripple US medical research?

   Udgivet: 14.2.2025
10. DEI Under Trump: What It Means for Clinical Trials

    Udgivet: 13.2.2025
11. CAPA & RCA: A Must for Pharma M&A

    Udgivet: 12.2.2025
12. Trump Targets Indirect Costs in NIH Funding

    Udgivet: 11.2.2025
13. The USAID Halt and Its Consequences for Clinical Research

    Udgivet: 10.2.2025
14. Ebola Vaccine Trial in Record Time!

    Udgivet: 8.2.2025
15. Your Clinical Trial Site M&A Agreement is Exposing You to Risk

    Udgivet: 7.2.2025
16. What Does ICH E6 R3 Say About Returning Data to Participants?

    Udgivet: 5.2.2025
17. Navigating the Ongoing HHS Communication Freeze

    Udgivet: 4.2.2025
18. Ordinary People Are Changing Medicine

    Udgivet: 3.2.2025
19. Trump’s First 10 Days: The Impact on Clinical Trials

    Udgivet: 31.1.2025
20. Selling a Business with Issues

    Udgivet: 31.1.2025